What medication is prescribed for motion sickness?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Medication for Motion Sickness

For motion sickness prevention, scopolamine transdermal patch is the first-line medication, applied behind the ear at least 6-8 hours before anticipated motion exposure, with each patch lasting approximately 3 days. 1, 2, 3

First-Line Treatment: Scopolamine

  • Scopolamine transdermal patch (1.5 mg) should be applied behind the ear 6-8 hours before the anti-motion sickness effect is needed, as this anticholinergic medication blocks acetylcolina to reduce neural mismatch that causes motion sickness 1, 2

  • Each patch provides protection for approximately 3 days of continuous use 1, 2

  • Scopolamine is FDA-approved specifically for prevention of nausea and vomiting from motion sickness in adults 2

Second-Line Treatment: Antihistamines

When scopolamine cannot be used due to contraindications or side effects, antihistamines are the alternative:

  • Meclizine 12.5-25 mg three times daily is the most commonly recommended antihistamine, working by suppressing the central emetic center 1, 4

  • Meclizine is probably more effective than placebo at preventing motion sickness symptoms under natural conditions (40% vs 25% symptom prevention) 5

  • Dimenhydrinate (another first-generation antihistamine) is also effective and has been shown to reduce both motion sickness symptoms and gastric tachyarrhythmia 6

Severe Cases: Combination or Alternative Therapy

  • For severe motion sickness requiring rapid onset, promethazine 12.5-25 mg can be used, though it carries risks of hypotension, respiratory depression, and extrapyramidal effects 1

  • Combination therapy with scopolamine patch plus meclizine provides complementary mechanisms of action for severe symptoms 1

Critical Contraindications and Warnings

Scopolamine is absolutely contraindicated in:

  • Angle-closure glaucoma 2
  • Allergy to scopolamine or belladonna alkaloids 2

Use scopolamine with extreme caution in:

  • Open-angle glaucoma (can precipitate angle closure) 2
  • Elderly patients (higher risk of anticholinergic side effects and falls) 1, 7
  • Pregnant women with preeclampsia (risk of seizures) 2
  • Patients with urinary retention, seizure history, or psychosis 2

Important Side Effects to Counsel Patients About

Scopolamine commonly causes:

  • Blurred vision and dilated pupils (especially if patch contacts eyes) 2
  • Dry mouth 2
  • Sedation 2
  • Withdrawal symptoms if used for several days then stopped abruptly (dizziness, nausea, vomiting, confusion) 2

Antihistamines commonly cause:

  • Sedation (66% with antihistamines vs 44% with placebo) 5
  • Anticholinergic effects, though less pronounced than scopolamine 4
  • Increased fall risk, particularly in elderly patients 1, 4

Medications That Do NOT Work

  • Nonsedating antihistamines are NOT effective for motion sickness prevention 3
  • Ondansetron is NOT effective for motion sickness 3
  • Ginger root is NOT effective for motion sickness 3

Duration of Use Warning

  • Vestibular suppressant medications should only be used short-term (during acute exposure), not as long-term treatment, as they can interfere with vestibular compensation and central adaptation 1, 4, 7

  • For conditions like Ménière's disease that may be confused with motion sickness, these medications should only be used during acute attacks, not continuously 4, 7

Special Populations

  • Safety and effectiveness in children have not been established for scopolamine transdermal system 2

  • Pregnant women should discuss risks versus benefits, as scopolamine passes into breast milk and severe preeclampsia patients have experienced seizures with injectable scopolamine 2

  • Elderly patients require closer monitoring due to significantly increased risk of falls and anticholinergic toxicity 1

References

Guideline

Tratamiento para Cinetosis Severa

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Prevention and treatment of motion sickness.

American family physician, 2014

Guideline

Management of Non-BPPV Peripheral Vertigo

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Antihistamines for motion sickness.

The Cochrane database of systematic reviews, 2022

Guideline

Scopolamine for Vertigo Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.